{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:33:51Z","timestamp":1782398031760,"version":"3.54.5"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Importance:<\/jats:bold>Retinopathy of prematurity (ROP) is a preventable cause of blindness in children. Without treatment, more than 45% of eyes may suffer permanent vision loss. Current ROP screening guidelines, which include a range of birth weights (BWs) and gestational ages (GAs), may require screening many low-risk preemies who might develop severe ROP.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold>All high-risk infants in the neonatal intensive care unit (NICU) of the First Affiliated Hospital of Zhengzhou University from 2017 to 2021 were included in this retrospective cohort study. Each of the 27 candidate risk factors was evaluated in univariate analysis and adjusted for known risk factors (i.e., GA and BW). The significant results were analyzed in a backward selection multivariate logistic regression model. Receiver operating characteristic (ROC) curves and a nomogram were drawn.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>The study included 2,040 infants who underwent ROP screening. The weight gain rate [OR, 2.65; 95% confidence interval (CI), 1.49\u20131.21 \u2264 12 g\/d vs. &amp;gt; 18 g\/d;<jats:italic>P<\/jats:italic>= 0.001], blood transfusion (OR, 2.03; 95% CI, 1.14\u20133.64;<jats:italic>P<\/jats:italic>= 0.017), invasive mechanical ventilation (OR, 1.74; 95% CI, 1.15\u20132.66;<jats:italic>P<\/jats:italic>= 0.009) and N-terminal segment of pro-B-type natriuretic peptide (NT-proBNP) \u2265 25,000 ng\/L (OR, 1.51; 95% CI, 1.00\u20132.28;<jats:italic>P<\/jats:italic>= 0.048) were four new statistically independent risk factors in addition to GA and BW. The area under the curve (AUC) of the final multivariate model was 0.90 (95% CI, 0.88\u20130.92;<jats:italic>P<\/jats:italic>&amp;lt; 0.001).<\/jats:p><jats:p><jats:bold>Conclusions and Relevance:<\/jats:bold>These findings add to our understanding of ROP screening because they include all eligible infants rather than only high-risk infants, as in previous studies. Under the control of BW and GA, low weight gain rate, increased number of blood transfusion, invasive mechanical ventilation and NT-proBNP \u2265 25,000 ng\/L were \u201cnew\u201d statistically independent risk factors for ROP. The ROP risk can be calculated manually or represented by a nomogram for clinical use.<\/jats:p>","DOI":"10.3389\/fped.2021.697690","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T05:26:56Z","timestamp":1625030816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Good Way to Reduce Screening for Retinopathy of Prematurity: Development of the ROP Model in a China Preterm Population"],"prefix":"10.3389","volume":"9","author":[{"given":"Wenqian","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peige","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/bjophthalmol-2016-310041","article-title":"International variations and trends in the treatment for retinopathy of prematurity","volume":"101","author":"Darlow","year":"2017","journal-title":"Br J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e20150389","DOI":"10.1542\/peds.2015-0389","article-title":"A multifaceted approach to improving outcomes in the NICU: the pediatrix 100 000 babies campaign","volume":"137","author":"Ellsbury","year":"2016","journal-title":"Pediatrics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1542\/peds.2010-0090","article-title":"Retinopathy of prematurity in 7 neonatal units in Rio de janeiro: screening criteria and workload implications","volume":"126","author":"Zin","year":"2010","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3760\/cma.j.issn.0366-6999.2010.20.033","article-title":"Retinopathy of prematurity: an epidemic in the making","volume":"123","author":"Quinn","year":"2010","journal-title":"Chin Med J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0116669","DOI":"10.1371\/journal.pone.0116669","article-title":"Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000079542","article-title":"Screening for retinopathy of prematurity: is it painful?","volume":"86","author":"Belda","year":"2004","journal-title":"Biol Neonate."},{"key":"B13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/jp.2012.149","article-title":"The pain response to mydriatic eyedrops in preterm infants","volume":"33","author":"Cohen","year":"2013","journal-title":"J Perinatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1542\/peds.2007-0644","article-title":"Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996 2005): is the incidence increasing?","volume":"121","author":"Slidsborg","year":"2008","journal-title":"Pediatrics."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13506120500032790","article-title":"Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore","volume":"34","author":"Shah","year":"2005","journal-title":"Ann Acad Med Singap."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1542\/peds.65.6.1096","article-title":"Risk factors in retrolental fibroplasia","volume":"65","author":"Gunn","year":"1980","journal-title":"Pediatrics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3928\/0191-3913-19900901-13","article-title":"Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia","volume":"27","author":"Brown","year":"1990","journal-title":"J Pediatr Ophthalmol Strabismus."},{"key":"B19","first-page":"376","article-title":"The relationship of blood transfusions to retrolental fibroplasia","volume":"15","author":"Mittelman","year":"1983","journal-title":"Ann Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1365-3016.2003.00545.x","article-title":"Postnatal risk factors of retinopathy of prematurity","volume":"18","author":"Kim","year":"2004","journal-title":"Paediatr Perinat Epidemiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2431-5-18","article-title":"Retinopathy of prematurity and risk factors: a prospective cohort study","volume":"5","author":"Karna","year":"2005","journal-title":"BMC Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/pr.2017.179","article-title":"N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity","volume":"82","author":"B\u00fchrer","year":"2017","journal-title":"Pediatr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1542\/peds.2011-0603","article-title":"Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity","volume":"128","author":"Czernik","year":"2011","journal-title":"Pediatrics."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/ATVBAHA.116.307545","article-title":"N-Terminal Pro-B-Type natriuretic peptide is related to retinal microvascular damage: the rotterdam study","volume":"36","author":"Mutlu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3760\/cma.j.issn.2095-428X.2013.23.023","article-title":"Guidelines for therapeutic use of oxygen and prevention and treatment of retinopathy in premature infants (Revised)","volume":"4","author":"Association","year":"2016","journal-title":"Chin J Appl Clin Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-0034-1385857","article-title":"[New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany]","volume":"218","author":"Voigt","year":"2014","journal-title":"Z Geburtshilfe Neonatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Res Cri Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"F337","DOI":"10.1136\/archdischild-2017-313574","article-title":"Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis","volume":"103","author":"Gerull","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaophthalmol.2014.5185","article-title":"Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study","volume":"133","author":"Ying","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1542\/peds.2010-2240","article-title":"A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain","volume":"127","author":"Binenbaum","year":"2011","journal-title":"Pediatrics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/bjophthalmol-2013-303123","article-title":"Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria","volume":"97","author":"van Sorge","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study","volume":"116","author":"Good","year":"2005","journal-title":"Pediatrics."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1001\/archopht.121.12.1697","article-title":"Risk analysis of prethreshold retinopathy of prematurity","volume":"121","author":"Hardy","year":"2003","journal-title":"Arch Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0161-6420(93)31665-9","article-title":"Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group","volume":"100","author":"Schaffer","year":"1993","journal-title":"Ophthalmology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3760\/cma.j.cn101070-20200201-00109","article-title":"Weishengqi xueliu donglixue yu zaochaner shiwangmo bingbian xiangguan yanjiu [Study on the relaotionship between perinatal hemodynamics and retinopathy of prematurity]","volume":"35","author":"Min","year":"2020","journal-title":"Chin J Appl Clin Pediatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ophtha.2015.12.019","article-title":"Neonatal risk factors for treatment-demanding retinopathy of prematurity: a danish national study","volume":"123","author":"Slidsborg","year":"2016","journal-title":"Ophthalmology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/NPM-15814128","article-title":"Retinopathy of prematurity: risk factors and variability in canadian neonatal intensive care units","volume":"8","author":"Thomas","year":"2015","journal-title":"J Neonatal Perinatal Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.CCM.0000261893.72811.0F","article-title":"Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock","volume":"35","author":"Varpula","year":"2007","journal-title":"Cri Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1537-2995.2008.01656.x","article-title":"N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload","volume":"48","author":"Tobian","year":"2008","journal-title":"Transfusion."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1210\/endo.142.4.8099","article-title":"Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis","volume":"142","author":"Pedram","year":"2001","journal-title":"Endocrinology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2353\/ajpath.2009.090439","article-title":"Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization","volume":"175","author":"Lara-Castillo","year":"2009","journal-title":"Am J Pathol."},{"key":"B45","first-page":"15","article-title":"Natriuretic peptide system in the human retina","volume":"10","author":"Roll\u00edn","year":"2004","journal-title":"Mol Vision."},{"key":"B46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/bjo.82.7.830","article-title":"Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour","volume":"82","author":"Salzmann","year":"1998","journal-title":"Br J Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000027482","article-title":"Risk factors in retinopathy of prematurity","volume":"214","author":"Seiberth","year":"2000","journal-title":"A multivariate statistical analysis. Ophthalmologica."},{"key":"B51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1067\/mpa.2000.110342","article-title":"Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity","volume":"4","author":"Wallace","year":"2000","journal-title":"J AAPOS."},{"key":"B52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5271\/sjweh.833","article-title":"Risk factors of threshold retinopathy of prematurity","volume":"41","author":"Dutta","year":"2004","journal-title":"Indian Pediatr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaapos.2006.05.007","article-title":"Risk factors in the development of mild and severe retinopathy of prematurity","volume":"10","author":"Akkoyun","year":"2006","journal-title":"J AAPOS."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e19961","DOI":"10.1097\/MD.0000000000019961","article-title":"Transfusion rates and disease spectrum in neonates treated with blood transfusion in China","volume":"99","author":"Sun","year":"2020","journal-title":"Medicine."},{"key":"B55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clp.2013.02.001","article-title":"Retinopathy of prematurity-incidence today","volume":"40","author":"Zin","year":"2013","journal-title":"Clin Perinatol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.697690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T02:19:15Z","timestamp":1672625955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.697690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":55,"alternative-id":["10.3389\/fped.2021.697690"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.697690","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"article-number":"697690"}}